137 related articles for article (PubMed ID: 31725952)
1. A novel mutation in USF1 gene is associated with familial combined hyperlipidemia.
Taghizadeh E; Mirzaei F; Jalilian N; Ghayour Mobarhan M; Ferns GA; Pasdar A
IUBMB Life; 2020 Apr; 72(4):616-623. PubMed ID: 31725952
[TBL] [Abstract][Full Text] [Related]
2. A novel variant in LPL gene is associated with familial combined hyperlipidemia.
Taghizadeh E; Ghayour-Mobarhan M; Ferns GA; Pasdar A
Biofactors; 2020 Jan; 46(1):94-99. PubMed ID: 31599081
[TBL] [Abstract][Full Text] [Related]
3. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the complex genetics of familial combined hyperlipidemia.
Suviolahti E; Lilja HE; Pajukanta P
Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
[TBL] [Abstract][Full Text] [Related]
5. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
[TBL] [Abstract][Full Text] [Related]
6. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
[TBL] [Abstract][Full Text] [Related]
7. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
8. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
Coon H; Xin Y; Hopkins PN; Cawthon RM; Hasstedt SJ; Hunt SC
Hum Genet; 2005 Sep; 117(5):444-51. PubMed ID: 15959806
[TBL] [Abstract][Full Text] [Related]
9. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies.
Reiner AP; Carlson CS; Jenny NS; Durda JP; Siscovick DS; Nickerson DA; Tracy RP
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2736-42. PubMed ID: 17885212
[TBL] [Abstract][Full Text] [Related]
10. Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
Hoffer MJ; Bredie SJ; Snieder H; Reymer PW; Demacker PN; Havekes LM; Boomsma DI; Stalenhoef AF; Frants RR; Kastelein JJ
Atherosclerosis; 1998 May; 138(1):91-9. PubMed ID: 9678774
[TBL] [Abstract][Full Text] [Related]
11. Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q.
Zeggini E; Damcott CM; Hanson RL; Karim MA; Rayner NW; Groves CJ; Baier LJ; Hale TC; Hattersley AT; Hitman GA; Hunt SE; Knowler WC; Mitchell BD; Ng MC; O'Connell JR; Pollin TI; Vaxillaire M; Walker M; Wang X; Whittaker P; Xiang K; Jia W; Chan JC; Froguel P; Deloukas P; Shuldiner AR; Elbein SC; McCarthy MI;
Diabetes; 2006 Sep; 55(9):2541-8. PubMed ID: 16936202
[TBL] [Abstract][Full Text] [Related]
12. USF1 and dyslipidemias: converging evidence for a functional intronic variant.
Naukkarinen J; Gentile M; Soro-Paavonen A; Saarela J; Koistinen HA; Pajukanta P; Taskinen MR; Peltonen L
Hum Mol Genet; 2005 Sep; 14(17):2595-605. PubMed ID: 16076849
[TBL] [Abstract][Full Text] [Related]
13. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
Di Taranto MD; Staiano A; D'Agostino MN; D'Angelo A; Bloise E; Morgante A; Marotta G; Gentile M; Rubba P; Fortunato G
Mol Cell Probes; 2015 Feb; 29(1):19-24. PubMed ID: 25308402
[TBL] [Abstract][Full Text] [Related]
14. Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex.
Wijsman EM; Brunzell JD; Jarvik GP; Austin MA; Motulsky AG; Deeb SS
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):215-26. PubMed ID: 9484986
[TBL] [Abstract][Full Text] [Related]
15. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
16. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
Campagna F; Montali A; Baroni MG; Maria AT; Ricci G; Antonini R; Verna R; Arca M
Metabolism; 2002 Oct; 51(10):1298-305. PubMed ID: 12370850
[TBL] [Abstract][Full Text] [Related]
17. Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E; Farahani N; Mardani R; Taheri F; Taghizadeh H; Gheibihayat SM
Biochem Genet; 2022 Apr; 60(2):453-481. PubMed ID: 34478023
[TBL] [Abstract][Full Text] [Related]
18. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
Hopkins PN; Heiss G; Ellison RC; Province MA; Pankow JS; Eckfeldt JH; Hunt SC
Circulation; 2003 Aug; 108(5):519-23. PubMed ID: 12847072
[TBL] [Abstract][Full Text] [Related]
20. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
